Pharmacogenomic studies with a combination therapy in Alzheimer's disease

被引：18

作者：

Cacabelos, R ^{[1
]}

Fernández-Novoa, L ^{[1
]}

Pichel, V ^{[1
]}

Lombardi, P ^{[1
]}

Kubota, Y ^{[1
]}

Takeda, M ^{[1
]}

机构：

[1] Inst CNS Disorders, EuroEspes Biomed Res Ctr, Bergondo 15166, Coruna, Spain

来源：

MOLECULAR NEUROBIOLOGY OF ALZHEIMER DISEASE AND RELATED DISORDERS | 2004年

关键词：

D O I：

10.1159/000078531

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 [法学]; 0303 [社会学]; 100203 [老年医学];

摘要：

引用

页码：94 / 107

页数：14

共 25 条

[1]

Alvarez XA, 1999, METHOD FIND EXP CLIN, V21, P633

[2]

Alvarez XA, 2000, METHOD FIND EXP CLIN, V22, P585

[3]

ALVAREZ XA, 1997, CNS DRUG REV, V3, P181

[4]

Cacabelos R, 2000, Drug News Perspect, V13, P252

[5]

Pharmacogenomics for the treatment of dementia [J].

Cacabelos, R .

ANNALS OF MEDICINE, 2002, 34 (05) :357-379

[6]

Therapeutic effects of CDP-choline in Alzheimer's disease - Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors [J].

Cacabelos, R ;

Caamano, J ;

Gomez, MJ ;

FernandezNovoa, L ;

FrancoMaside, A ;

Alvarez, XA .

NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 :399-403

[7]

A pharmacogenomic approach to Alzheimer's disease [J].

Cacabelos, R ;

Alvarez, A ;

Fernández-Novoa, L ;

Lombardi, VRM .

ACTA NEUROLOGICA SCANDINAVICA, 2000, 102 :12-19

[8]

Cacabelos R, 2000, DRUG TODAY, V36, P415

[9]

Cacabelos R, 1996, ACTA NEUROL SCAND, V93, P72

[10]

CACABELOS R, 1997, CLIN PSYCHIATR, P73

← 1 2 3 →